Hair & Alopecia Formulations

Minoxidil topical solution (5% w/v) is a vasodilator and hair growth stimulant on the WHO Model List of Essential Medicines. It shortens the telogen (resting) phase, induces early entry into anagen (growth), increases hair follicle diameter, and enhances microvascular blood flow to the follicular papilla. Indicated for the treatment of androgenetic alopecia (pattern baldness) in men and women.

Minoxidil (5%) and Finasteride (0.1%) topical solution is an advanced dual-action therapy for male androgenetic alopecia (male pattern baldness). Minoxidil stimulates dermal papilla vascular endothelial growth factor (VEGF), opens potassium channels, and prolongs the anagen (growth) phase of hair follicles, while topical finasteride selectively inhibits type II 5-alpha reductase in the scalp, lowering local dihydrotestosterone (DHT) levels by up to 70% with substantially less systemic exposure than oral finasteride. Indicated for male androgenetic alopecia of the vertex and anterior scalp.